Drugs / AZD1940
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00689780 | Mar → Nov 2008 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00659490 | Feb → May 2008 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD1940 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00689780 ↗ |
| Route | Oral | “800ug oral administration” NCT00659490 ↗ |